Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2021

WHO access to meaningful medicines

Role of cancer drugs on WHO EML

Date

21 Sep 2021

Session

WHO access to meaningful medicines

Presenters

Lorenzo Moja

Authors

L. Moja

Author affiliations

  • WHO - World Health Organization, 1211 - Geneva/CH

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Introduction

Presenter: E.G. Elisabeth de Vries

Session: WHO access to meaningful medicines

Resources:

Webcast

ESMO’s reimbursement model

Presenter: Panagiotis Kanavos

Session: WHO access to meaningful medicines

Resources:

Slides

Webcast

Q&A and live discussion

Presenter: Elisabeth de Vries

Session: WHO access to meaningful medicines

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.